Fosfomycin-TF (Fosfomycin)

Antituberculous polypeptide antibiotic with low toxicity and and good tolerance. It is used for the treatment of drug-resistant forms of pulmonary tuberculosis.

The active ingredient of Claribaccin is clarithromycin. Clarithromycin is a semisynthetic macrolide antibiotic derived by substitution of CN3O hydroxyl group by (OH) group in the 6th position of the lactone ring of erythromycin, more precisely, clarithromycin is 6-Omethylerythromycin A. The mechanism of action of clarithromycin is based on binding to 50S ribosomal subunit of sensitive bacteria, which prevents the translocation of activated amino acids. Clarithromycin inhibits intracellular protein synthesis of microorganisms sensitive thereto and thereby exerts its antibacterial action.

Reliable choice in treatment of acquired microbial resistance. Especially active against gram-negative (-) bacteria. Most active against Pseudomonas aeruginosa, Acinetobacter baumannii, Citrobacter spp. Used parenterally in treatment of serious infections of lower respiratory tract and urinary system when widely used systemic antibiotics are ineffective because of development of bacterial resistance. Inhalational administration is recommended for patients with mucoviscidosis.

Reliable choice in treatment of acquired microbial resistance. Especially active against gram-negative (-) bacteria. Most active against Pseudomonas aeruginosa, Acinetobacter baumannii, Citrobacter spp. Used parenterally in treatment of serious infections of lower respiratory tract and urinary system when widely used systemic antibiotics are ineffective because of development of bacterial resistance. Inhalational administration is recommended for patients with mucoviscidosis.